The Iressa Pan‐Asia Study (IPASS) established the crucial role of epidermal growth factor receptor (EGFR) in the progression of lung cancer,11 which has initiated a new direction to individualize and design clinical treatment of lung cancer patients. The gene discussed is EGFR; the disease is lung carcinoma.